Equillium (EQ)

• Market cap: $132M
• 1 day: 1.96%
• 5 days: -3.26%
• 1 month: 1.96%
• 3 months: 37.75%
• 6 months: 34.19%
• Year to date: 35.95%
• 1 year: 407.32%
• 5 years: -67.4%
• 10 years: -85.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Employees: 14